Halogenated inhalational anaesthetics

Best Practice and Research: Clinical Anaesthesiology

Volumn 17, Issue 1, 2003, Pages 29-46

  Reichle, Florian M ^a   Conzen, Peter F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Compound A; Desflurane; Enflurane; Fluoride; Halothane; Halothane hepatitis; Hepatic injury; Hepatotoxicity; Isoflurane; Nephrotoxicity; Sevoflurane; Volatile anaesthetic drug

Indexed keywords

2,2 DIFLUORO 1 (TRIFLUOROMETHYL)VINYL FLUOROMETHYL ETHER; ABSORBENT; ALANINE AMINOTRANSFERASE; BILIRUBIN; CARBON DIOXIDE; DESFLURANE; ENFLURANE; FLUORIDE; GLUTATHIONE TRANSFERASE; HALOTHANE; HEXAFLUORO 2 PROPANOL; INHALATION ANESTHETIC AGENT; ISOFLURANE; METHOXYFLURANE; NITROUS OXIDE; SEVOFLURANE; THIOPENTAL; TRIFLUOROACETIC ACID; DRUG DERIVATIVE; ETHER DERIVATIVE; FLUORINATED HYDROCARBON; FLUOROMETHYL 2,2-DIFLUORO-1-(TRIFLUOROMETHYL)VINYL ETHER;

ACETYLATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY PRODUCTION; ARTHRALGIA; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CHEMICAL REACTION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG ELIMINATION; DRUG ERUPTION; DRUG METABOLISM; DRUG UPTAKE; ENDOPLASMIC RETICULUM; ENZYME DEFECT; EOSINOPHILIA; FEVER; GASTROINTESTINAL SYMPTOM; HALOGENATION; HUMAN; HUMORAL IMMUNITY; JAUNDICE; KIDNEY INJURY; LIVER CELL DAMAGE; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; MITOCHONDRION SWELLING; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RENAL SYSTEM PARAMETERS; REVIEW; RODENT; SURGICAL PATIENT; ANIMAL; ANTIBODY SPECIFICITY; DRUG EFFECT; KIDNEY; LIVER;

ANESTHETICS, INHALATION; ANIMALS; ENFLURANE; ETHERS; HALOTHANE; HUMANS; HYDROCARBONS, FLUORINATED; ISOFLURANE; KIDNEY; LIVER; METHYL ETHERS; ORGAN SPECIFICITY;

EID: 0038387346     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2002.0265     Document Type: Article

References (101)

1. Rao GS Grumley JO Extrahepatic tissue distribution, covalent binding, and toxicity of halothane in control and phenobarbital-pretreated rats Pharmacology and Therapeutics in Dentistry 3 1978 101-109
2. Gourlay GK Adams JF Cousins MJ et al. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model British Journal of Anaesthesiology 52 1980 331-336
3. Christ DD Kenna JG Kammerer W et al. Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis Anesthesiology 69 1988 833-838
4. Kharasch ED Thummel KE Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane Anesthesiology 79 1993 795-807
5. Koblin DD Characteristics and implications of desflurane metabolism and toxicity Anesthesia & Analgesia 75 1992 S10-S16
6. Frink E -JJ Brown B-RJ Sevoflurane Bailliere Best Practice & Research Clinical Anaesthesiology 4 1993 899-913
7. Shiraishi Y Ikeda K Uptake and biotransformation of sevoflurane in humans: a comparative study of sevoflurane with halothane, enflurane, and isoflurane Journal of Clinical Anesthesiology 2 1990 381-386
8. Fang ZX Eger EI Laster MJ et al. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme Anesthesia & Analgesia 80 1995 1187-1193
9. Frink E-JJ Nogami WM Morgan SE et al. High carboxyhemoglobin concentrations occur in swine during desflurane anesthesia in the presence of partially dried carbon dioxide absorbents Anesthesiology 87 1997 308-316
10. Higuchi H Adachi Y Arimura S et al. Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents Anesthesia & Analgesia 91 2000 434-439
11. Funk W Gruber M Wild K et al. Dry soda lime markedly degrades sevoflurane during simulated inhalation induction British Journal of Anaesthesiology 82 1999 193-198
12. Murray JM Renfrew CW Bedi A et al. Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems Anesthesiology 91 1999 1342-1348
13. Forster H Behne M Warnken UH et al. Die Anwendung von Lithiumhydroxid als Kohlendioxidabsorbens verhindert das Entstehen von Compound A wahrend Sevoflurananasthesie. [The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia.] Anaesthetist 49 2000 106-112
14. Bunker J P Forrest W H Mosteller F et al. The National Halothane Study: a Study of the Possible Association Between Halothane Anesthesia and Postoperative Hepatic Necrosis 1969 Bethesda, Maryland: US Goverment Printing Office
15. Wright R Eade OE Chrisholm M et al. Controlled prospective study of the effect on liver function of multiple exposures to halothane Lancet 1 1975 817-820
16. Conzen P Effects of inhalation anaesthetics on the liver Baillierere's Best Practice & Research Clinical Anaesthesiology 4 1993 1015-1034
17. Satoh H Fukuda Y Anderson DK et al. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes Journal of Pharmacology and Experimental Therapeutics 233 1985 857-862
18. Carrigan TW Straughen WJ A report of hepatic necrosis and death following isoflurane anesthesia Anesthesiology 67 1987 581-583
19. Martin JL Plevak DJ Flannery KD Hepatotoxicity after desflurane anesthesia Anesthesiology 83 1995 1125-1129
20. Ghantous H Fernando J Gandolfi AJ et al. Inhibition of protein synthesis and secretion by volatile anesthetics in guinea pig liver slices Advances in Experimental Biology and Medicine 283 1991 725-730
21. Ghantous HN Fernando J Gandolfi AJ et al. Minimal biotransformation and toxicity of desflurane in guinea pig liver slices Anesthesia & Analgesia 72 1991 796-800
22. Ghantous HN Fernando J Gandolfi AJ et al. Toxicity of halothane in guinea pig liver slices Toxicology 62 1990 59-69
23. Ghantous HN Fernando J Gandolfi AJ et al. Sevoflurane is biotransformed by guinea pig liver slices but causes minimal cytotoxicity Anesthesia & Analgesia 75 1992 436-440
24. Marit GB Dodd DE George ME et al. Hepatotoxicity in guinea pigs following acute inhalation exposure to 1,1-dichloro-2,2,2-trifluoroethane Toxicology and Pathology 22 1994 404-414
25. Lind RC Gandolfi AJ Hall PD Subanesthetic halothane is hepatotoxic in the guinea pig Anesthesia & Analgesia 74 1992 559-563
26. Kinugawa H Kawahara M Amakata Y et al. Halothane-induced cytotoxicity in isolated rat hepatocytes: an electron microscopic study In Vivo 7 1993 497-501
27. Noseworthy MD Janzen EG Towner RA et al. In vivo study of halothane hepatotoxicity in the rat using magnetic resonance imaging and 31P spectroscopy Journal of Biochemical & Biophysical Methods 34 1997 107-122
28. Eger EI Johnson BH Strum DP et al. Studies of the toxicity of I-653, halothane, and isoflurane in enzyme-induced, hypoxic rats Anesthesia & Analgesia 66 1987 1227-1229
29. Lind RC Gandolfi AJ Covalent binding of oxidative biotransformation reactive intermediates to protein influences halothane-associated hepatotoxicity in guinea pigs Advances in Experimental Medicine and Biology 283 1991 763-766
30. Lind RC Gandolfi AJ Hall PD Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs Anesthesiology 73 1990 1208-1213
31. Njoku D Laster MJ Gong DH et al. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury Anesthesia & Analgesia 84 1997 173-178
32. Cousins MJ Gourlay GK Knights KM et al. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans Anesthesia & Analgesia 66 1987 299-308
33. Hussey AJ Aldridge LM Paul D et al. Plasma glutathione S-transferase concentration as a measure of hepatocellular integrity following a single general anaesthetic with halothane, enflurane or isoflurane British Journal of Anaesthesiology 60 1988 130-135
34. Sindelar WF Tralka TS Gibbs PS Evidence for acute cellular changes in human hepatocytes during anesthesia with halogenated agents: an electron microscopic study Surgery 92 1982 520-527
35. Ray DC Drummond GB Halothane hepatitis British Journal of Anaesthesiology 67 1991 84-99
36. Kenna JG Neuberger J Williams R Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis Journal of Pharmacology and Experimental Therapeutics 242 1987 733-740
37. Kitteringham NR Kenna JG Park BK Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis British Journal of Clinical Pharmacology 40 1995 379-386
38. Eliasson E Gardner I Hume-Smith H et al. Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis Chemical and Biological Interaction 116 1998 123-141
39. Vergani D Tsantoulas D Eddleston AL et al. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia Lancet 2 1978 801-803
40. Kenna JG Jones RM The organ toxicity of inhaled anesthetics Anesthesia & Analgesia 81 1995 S51-S66
41. Christ DD Satoh H Kenna JG et al. Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane Drug Metabolism and Disposition 16 1988 135-140
42. Meldrum DJ Griffiths R Kenna JG Gallstones and isoflurane hepatitis Anaesthesia 53 1998 905-909
43. Njoku DB Shrestha S Soloway R et al. Subcellular localization of trifluoroacetylated liver proteins in association with hepatitis following isoflurane Anesthesiology 96 2002 757-761
44. Berghaus TM Baron A Geier A et al. Hepatotoxicity following desflurane anesthesia Hepatology 29 1999 613-614
45. Kenna JG Satoh H Christ DD et al. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane Journal of Pharmacology and Experimental Therapeutics 245 1988 1103-1109
46. Martin JL Kenna JG Pohl LR Antibody assays for the detection of patients sensitized to halothane Anesthesia & Analgesia 70 1990 154-159
47. Moult PJ Sherlock S Halothane-related hepatitis. A clinical study of twenty-six cases Quarterly Journal of Medicine 44 1975 99-114
48. Martin JL Dubbink DA Plevak DJ et al. Halothane hepatitis 28 years after primary exposure Anesthesia & Analgesia 74 1992 605-608
49. Kenna JG Neuberger J Mieli-Vergani G et al. Halothane hepatitis in children British Medical Journal 294 1987 1209-1211
50. Lewis JH Zimmerman HJ Ishak KG et al. Enflurane hepatotoxicity. A clinicopathologic study of 24 cases Annals of Internal Medicine 98 1983 984-992
51. Cook TL Beppu WJ Hitt BA et al. A comparison of renal effects and metabolism of sevoflurane and methoxyflurane in enzyme-induced rats Anesthesia & Analgesia 54 1975 829-835
52. Cook TL Beppu WJ Hitt BA et al. Renal effects and metabolism of sevoflurane in Fisher 3444 rats: anin-vivo and in-vitro comparison with methoxyflurane Anesthesiology 43 1975 70-77
53. Kusume Y [Inorganic fluoride concentrations and their sequential changes in the five layers of the kidney in rabbits after sevoflurane or methoxyflurane anesthesia.] Masui 48 1999 1202-1210
54. Hossain D Fujii K Yuge O et al. Dose-related sevoflurane metabolism to inorganic fluoride in rabbits Hiroshima Journal of Medical Science 40 1991 1-7
55. Kadota Y Sameshima T Miyao J et al. [Enzyme saturation of sevoflurane in piglets at clinically-used concentrations.] Masui 45 1996 167-172
56. Sun L Suzuki Y Takata M et al. [Repeated low-flow sevoflurane anesthesia: effects on hepatic and renal function in beagles.] Masui 46 1997 351-357
57. Kobayashi Y Ochiai R Takeda J et al. Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans Anesthesia & Analgesia 74 1992 753-757
58. Matsumura C Kemmotsu O Kawano Y et al. Serum and urine inorganic fluoride levels following prolonged low-dose sevoflurane anesthesia combined with epidural block Journal of Clinical Anesthesia 6 1994 419-424
59. Newman PJ Quinn AC Hall GM et al. Circulating fluoride changes and hepatorenal function following sevoflurane anaesthesia Anaesthesia 49 1994 936-939
60. Wiesner G Wild K Schwurzer S et al. Serumfluoridkonzentrationen und exokrine Nierenfunktion bei Anwendung von Sevofluran und Enfluran. [Serum fluoride concentrations and exocrine kidney function with sevoflurane and enflurane. An open, randomized, comparative phase III study of patients with healthy kidneys.] Anaesthetist 45 1996 31-36
61. Higuchi H Satoh T Arimura S et al. Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia Anesthesia & Analgesia 77 1993 1018-1021
62. Levine M F Sarner J Lerman J et al. Plasma inorganic fluoride concentrations after sevoflurane anesthesia in children Anesthesiology 84 1996 348-353
63. Funk W Moldaschl J Fujita Y et al. Sevofluran oder Halothan bei inhalativ eingeleiteten Narkosen im Kindesalter. [Sevoflurane or halothane in inhalational anesthesia induction in childhood. Anesthesia quality and fluoride level.] Anaesthetist 45 1996 22-30
64. Ni J Sato N Fujii K et al. Urinary excretion of hexafluoroisopropanol glucuronide and fluoride in patients after sevoflurane anaesthesia Journal of Pharmacy and Pharmacology 45 1993 67-69
65. 2O anesthesia Yonsei Medical Journal 35 1994 218-222
66. Frink EJ Ghantous H Malan TP et al. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function Anesthesia & Analgesia 74 1992 231-235
67. Frink EJ Malan TP Isner RJ et al. Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers Anesthesiology 80 1994 1019-1025
68. Bito H Ikeda K Plasma inorganic fluoride and intracircuit degradation product concentrations in long-duration, low-flow sevoflurane anesthesia Anesthesia & Analgesia 79 1994 946-951
69. Munday IT Stoddart PA Jones RM et al. Serum fluoride concentration and urine osmolality after enflurane and sevoflurane anesthesia in male volunteers Anesthesia & Analgesia 81 1995 353-359
70. Kharasch ED Hankins DC Thummel KE Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity Anesthesiology 82 1995 689-699
71. Conzen P F Nuscheler M Melotte A et al. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane Anesthesia & Analgesia 81 1995 569-575
72. Tsukamoto N Hirabayashi Y Shimizu R et al. The effects of sevoflurane and isoflurane anesthesia on renal tubular function in patients with moderately impaired renal function Anesthesia & Analgesia 82 1996 909-913
73. Ohira N Inada T Hamai R [Influence of sevoflurane and isoflurane anesthesia on renal function in elderly patients.] Masui 43 1994 1842-1845
74. Higuchi H Sumikura H Sumita S et al. Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia Anesthesiology 83 1995 449-458
75. Nishiyama T Hanaoka K Inorganic fluoride kinetics and renal and hepatic function after repeated sevoflurane anesthesia Anesthesia & Analgesia 87 1998 468-473
76. Wandel C Neff S Keppler G et al. The relationship between cytochrome P4502E1 activity and plasma fluoride levels after sevoflurane anesthesia in humans Anesthesia & Analgesia 85 1997 924-930
77. Gonsowski CT Laster MJ Eger EI et al. Toxicity of compound A in rats. Effect of a 3-hour administration Anesthesiology 80 1994 556-565
78. Kandel L Laster MJ Eger EI et al. Nephrotoxicity in rats undergoing a one-hour exposure to compound A Anesthesia & Analgesia 81 1995 559-563
79. Jin L Baillie TA Davis MR et al. Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether] in rats: evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate beta-lyase Biochemical and Biophysical Research Communications 210 1995 498-506
80. Jin L Davis MR Kharasch ED et al. Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane Chemical Research in Toxicology 9 1996 555-561
81. Iyer R A Anders M W Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A) Chemical Research in Toxicology 10 1997 811-819
82. Iyer RA Baggs RB Anders MW Nephrotoxicity of the glutathione and cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (Compound A) in male Fischer 344 rats Journal of Pharmacology and Experimental Therapeutics 283 1997 1544-1551
83. Kharasch ED Thorning D Garton K et al. Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats Anesthesiology 86 1997 160-171
84. Kharasch ED Hoffman GM Thorning D et al. Role of the renal cysteine conjugate beta-lyase pathway in inhaled compound A nephrotoxicity in rats Anesthesiology 88 1998 1624-1633
85. Martin JL Laster MJ Kandel L et al. Metabolism of compound A by renal cysteine-S-conjugate beta-lyase is not the mechanism of compound A-induced renal injury in the rat Anesthesia & Analgesia 82 1996 770-774
86. Njoku DB Pohl LR Sokoloski EA et al. Immunochemical evidence against the involvement of cysteine conjugate beta-lyase in compound A nephrotoxicity in rats Anesthesiology 90 1999 458-469
87. Uttamsingh V Iyer RA Baggs RB et al. Fate and toxicity of 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived mercapturates in male, Fischer 344 rats Anesthesiology 89 1998 1174-1183
88. Ebert TJ Messana LD Uhrich TD et al. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers Anesthesia & Analgesia 86 1998 662-667
89. Ebert TJ Frink EJ Kharasch ED Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers Anesthesiology 88 1998 601-610
90. Obata R Bito H Ohmura M et al. The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function Anesthesia & Analgesia 91 2000 1262-1268
91. Higuchi H Sumita S Wada H et al. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity Anesthesiology 89 1998 307-322
92. Higuchi H Wada H Usui Y et al. Effects of probenecid on renal function in surgical patients anesthetized with low-flow sevoflurane Anesthesiology 94 2001 21-31
93. Frink EJ Green WB Brown EA et al. Compound A concentrations during sevoflurane anesthesia in children Anesthesiology 84 1996 566-571
94. Eger EI Koblin DD Bowland T et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers Anesthesia & Analgesia 84 1997 160-168
95. Eger EI Gong D Koblin DD et al. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers Anesthesia & Analgesia 85 1997 1154-1163
96. Ebert TJ Frink E-JJ Kharasch ED Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers Anesthesiology 88 1998 601-610
97. Iyer RA Frink EJ Ebert TJ et al. Cysteine conjugate beta-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3, 3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A Anesthesiology 88 1998 611-618
98. Kharasch ED Hankins DC P450-dependent and nonenzymatic human liver microsomal defluorination of fluoromethyl-2, 2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product Drug Metabolism and Disposition 24 1996 649-654
99. Kharasch ED Jubert C Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison Anesthesiology 91 1999 1267-1278
100. Lash LH Nelson RM Van-Dyke RA et al. Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity Drug Metabolism and Disposition 18 1990 50-54
101. Conzen PF Kharasch ED Czeiner SFA et al. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficienty Anesthesiology 97 2002 578-584